Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06491238 · ClinicalTrials.gov registry record · NA
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
A NA study of Myasthenia Gravis, sponsored by HealthPartners Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06491238: Recruiting NA study of Myasthenia Gravis, sponsored by HealthPartners Institute.
NCT06491238 is a NA study of Myasthenia Gravis that is actively recruiting participants, run by HealthPartners Institute. The registered enrollment target is 20 participants, below the 191-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06491238, a NA study of Myasthenia Gravis, is actively recruiting participants, sponsored by HealthPartners Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of this pilot study is to examine the feasibility, acceptability, and tolerability of light and moderate intensity exercise in adults with MGeffect of light vs. moderate intensity exercise on health outcomes. Participants will be enrolled into the NeuroWell exercise program, which is geared toward individuals with neurological disorders or injuries and led by Certified Exercise Physiologists (CEPs) at the HealthPartners Neuroscience Center. A total of 20 people with MG will be enrolled in this study and participate in a small group exercise program 3 times a week for 12 weeks. Participants will be randomized into two exercise groups: 1) Light intensity or 2) Moderate intensity. We hypothesize that light and moderate intensity exercise will be feasible, acceptable, and tolerable in adults with MG and that individuals in the light intensity exercise group will be able to achieve the same improvement in health outcomes as the moderate intensity group.
Primary Outcome
Percent of participants recruited of potential participants contacted. Range: \[0-100\]. Higher percentage indicates higher feasibility
Conditions Studied
Interventions
- BEHAVIORAL Moderate Intensity Exercise
- BEHAVIORAL Light Intensity Exercise
Study Locations (1)
Minnesota
- HealthPartners Neuroscience Center - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06491238 shows while recruiting
NCT06491238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 191-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Myasthenia Gravis appearing as the primary indexed condition, and to 2 interventions - of which Moderate Intensity Exercise is the first listed.
NCT06491238 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06491238 about?
NCT06491238 is a clinical study titled "Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis". The overall purpose of this pilot study is to examine the feasibility, acceptability, and tolerability of light and moderate intensity exercise in adults with MGeffect of light vs. moderate intensity exercise on health outcomes. Participants will be enrolled into the NeuroWell exercise program, whic...
What is the current status of trial NCT06491238?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-09-16. Estimated completion is 2026-12.
What conditions does trial NCT06491238 study?
This clinical trial studies the following conditions: Myasthenia Gravis.
What interventions are being tested in trial NCT06491238?
The interventions under investigation include: Moderate Intensity Exercise (BEHAVIORAL), Light Intensity Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT06491238?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06491238 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06491238's enrollment target sits among peer trials
20 29th of 32 higher than 4 of 32 other Myasthenia Gravis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myasthenia Gravis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
SP Thoracic IDE Study
ACTIVE NOT RECRUITING · NA
-
Clinical Trial to Improve the Magnetic Levator Prosthesis
COMPLETED · NA
-
Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis
COMPLETED · NA
-
Acupuncture in Myasthenia Gravis (AcuMG)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI